Q32 BIO INC (QTTB) Fundamental Analysis & Valuation

NASDAQ:QTTB • US7469641051

Current stock price

6.67 USD
+0.86 (+14.8%)
At close:
6.57 USD
-0.1 (-1.5%)
After Hours:

This QTTB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. QTTB Profitability Analysis

1.1 Basic Checks

  • In the past year QTTB was profitable.
  • QTTB had a negative operating cash flow in the past year.
  • QTTB had negative earnings in 4 of the past 5 years.
  • QTTB had a negative operating cash flow in each of the past 5 years.
QTTB Yearly Net Income VS EBIT VS OCF VS FCFQTTB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • QTTB has a Return On Assets of 48.27%. This is amongst the best in the industry. QTTB outperforms 99.03% of its industry peers.
  • The Return On Equity of QTTB (70.98%) is better than 99.03% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 26.48%, QTTB belongs to the top of the industry, outperforming 98.46% of the companies in the same industry.
Industry RankSector Rank
ROA 48.27%
ROE 70.98%
ROIC 26.48%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QTTB Yearly ROA, ROE, ROICQTTB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin of QTTB (55.49%) is better than 98.26% of its industry peers.
  • Looking at the Operating Margin, with a value of 31.46%, QTTB belongs to the top of the industry, outperforming 96.33% of the companies in the same industry.
Industry RankSector Rank
OM 31.46%
PM (TTM) 55.49%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QTTB Yearly Profit, Operating, Gross MarginsQTTB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. QTTB Health Analysis

2.1 Basic Checks

  • QTTB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • QTTB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QTTB Yearly Shares OutstandingQTTB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
QTTB Yearly Total Debt VS Total AssetsQTTB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • QTTB has an Altman-Z score of 0.56. This is a bad value and indicates that QTTB is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of QTTB (0.56) is better than 61.39% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that QTTB is not too dependend on debt financing.
  • QTTB's Debt to Equity ratio of 0.08 is on the low side compared to the rest of the industry. QTTB is outperformed by 61.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC3.12
WACC8.49%
QTTB Yearly LT Debt VS Equity VS FCFQTTB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 4.85 indicates that QTTB has no problem at all paying its short term obligations.
  • With a Current ratio value of 4.85, QTTB perfoms like the industry average, outperforming 55.02% of the companies in the same industry.
  • QTTB has a Quick Ratio of 4.85. This indicates that QTTB is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 4.85, QTTB perfoms like the industry average, outperforming 56.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.85
Quick Ratio 4.85
QTTB Yearly Current Assets VS Current LiabilitesQTTB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. QTTB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 107.21% over the past year.
  • Measured over the past years, QTTB shows a very strong growth in Revenue. The Revenue has been growing by 81.88% on average per year.
EPS 1Y (TTM)107.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%414.66%
Revenue 1Y (TTM)N/A
Revenue growth 3Y155.81%
Revenue growth 5Y81.88%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -123.33% on average over the next years. This is quite bad
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-291.79%
EPS Next 2Y-123.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QTTB Yearly Revenue VS EstimatesQTTB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2025 2028 10M 20M 30M 40M 50M
QTTB Yearly EPS VS EstimatesQTTB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

3

4. QTTB Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 4.87 indicates a rather cheap valuation of QTTB.
  • QTTB's Price/Earnings ratio is rather cheap when compared to the industry. QTTB is cheaper than 98.84% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of QTTB to the average of the S&P500 Index (25.79), we can say QTTB is valued rather cheaply.
  • The Forward Price/Earnings Ratio is negative for QTTB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 4.87
Fwd PE N/A
QTTB Price Earnings VS Forward Price EarningsQTTB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QTTB indicates a rather cheap valuation: QTTB is cheaper than 99.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.68
QTTB Per share dataQTTB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • QTTB's earnings are expected to decrease with -123.33% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-123.33%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. QTTB Dividend Analysis

5.1 Amount

  • No dividends for QTTB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QTTB Fundamentals: All Metrics, Ratios and Statistics

Q32 BIO INC

NASDAQ:QTTB (3/19/2026, 4:12:23 PM)

After market: 6.57 -0.1 (-1.5%)

6.67

+0.86 (+14.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-10
Earnings (Next)05-06
Inst Owners50.56%
Inst Owner Change-4.8%
Ins Owners0.47%
Ins Owner Change-2.85%
Market Cap97.58M
Revenue(TTM)53.74M
Net Income(TTM)29.82M
Analysts82.22
Price Target15.3 (129.39%)
Short Float %3.16%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)283.15%
Min EPS beat(2)50.53%
Max EPS beat(2)515.77%
EPS beat(4)4
Avg EPS beat(4)154.13%
Min EPS beat(4)21.97%
Max EPS beat(4)515.77%
EPS beat(8)5
Avg EPS beat(8)9.36%
EPS beat(12)7
Avg EPS beat(12)2.66%
EPS beat(16)9
Avg EPS beat(16)2.92%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)32.35%
PT rev (3m)32.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.88%
EPS NY rev (3m)-1.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.87
Fwd PE N/A
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB 2.32
EV/EBITDA 2.68
EPS(TTM)1.37
EY20.54%
EPS(NY)-2.63
Fwd EYN/A
FCF(TTM)-2.29
FCFYN/A
OCF(TTM)-2.29
OCFYN/A
SpS3.67
BVpS2.87
TBVpS2.87
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.41
Profitability
Industry RankSector Rank
ROA 48.27%
ROE 70.98%
ROCE 33.52%
ROIC 26.48%
ROICexc 626.04%
ROICexgc 626.04%
OM 31.46%
PM (TTM) 55.49%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 0.2
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.85
Quick Ratio 4.85
Altman-Z 0.56
F-Score5
WACC8.49%
ROIC/WACC3.12
Cap/Depr(3y)18.28%
Cap/Depr(5y)36.72%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%414.66%
EPS Next Y-291.79%
EPS Next 2Y-123.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y155.81%
Revenue growth 5Y81.88%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y125.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.46%
OCF growth 3YN/A
OCF growth 5YN/A

Q32 BIO INC / QTTB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Q32 BIO INC?

ChartMill assigns a fundamental rating of 3 / 10 to QTTB.


What is the valuation status for QTTB stock?

ChartMill assigns a valuation rating of 3 / 10 to Q32 BIO INC (QTTB). This can be considered as Overvalued.


How profitable is Q32 BIO INC (QTTB) stock?

Q32 BIO INC (QTTB) has a profitability rating of 4 / 10.


What are the PE and PB ratios of Q32 BIO INC (QTTB) stock?

The Price/Earnings (PE) ratio for Q32 BIO INC (QTTB) is 4.87 and the Price/Book (PB) ratio is 2.32.


What is the financial health of Q32 BIO INC (QTTB) stock?

The financial health rating of Q32 BIO INC (QTTB) is 4 / 10.